These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 4588814)

  • 1. [Mode of action of oral antidiabetic drugs].
    Frey H
    Tidsskr Nor Laegeforen; 1973 Aug; 93(23):1591-5. PubMed ID: 4588814
    [No Abstract]   [Full Text] [Related]  

  • 2. Efficacy of centpiperalone in combination with biguanide & sulfonylurea.
    Srivastava PP; Murthy PS; Mukherjee SK
    Indian J Exp Biol; 1983 Jul; 21(7):390-2. PubMed ID: 6365752
    [No Abstract]   [Full Text] [Related]  

  • 3. Oral sulfonylurea agents suppress hepatic glucose production in non-insulin-dependent diabetic individuals.
    DeFronzo RA; Simonson DC
    Diabetes Care; 1984; 7 Suppl 1():72-80. PubMed ID: 6428844
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Biochemical viewpoint of the determination of the blood sugar decreasing and antidiabetic effect of sulfonylurea derivatives].
    Hasselblatt A
    Internist (Berl); 1966 Aug; 7(8):369-74. PubMed ID: 4863410
    [No Abstract]   [Full Text] [Related]  

  • 5. [Behavior of serum insulin under the influence of glisoxepide with and without butylbiguanide].
    Birk W; Petrides P
    Arzneimittelforschung; 1974 Mar; 24(0):425-9. PubMed ID: 4408033
    [No Abstract]   [Full Text] [Related]  

  • 6. Cellular loci of sulfonylurea actions.
    Lebovitz HE
    Diabetes Care; 1984; 7 Suppl 1():67-71. PubMed ID: 6376031
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Experimental studies on the mechanism of thrombocyte aggregation inhibition caused by sulfonylurea compounds. 2. Modification of blood sugar and thrombocyte aggregation by oral antidiabetics].
    Losert W; Hoder A; Scholz C
    Arzneimittelforschung; 1975 Feb; 25(2):170-9. PubMed ID: 804311
    [No Abstract]   [Full Text] [Related]  

  • 8. Effect of oral antidiabetic drugs on lipase activity in vitro.
    Holmes JH; Sapeika N; Zwarenstein H
    Res Commun Chem Pathol Pharmacol; 1975 Aug; 11(4):667-70. PubMed ID: 1179037
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mode of action of oral hypoglycaemic agents. II. Sulphonylureas & biguanides in rats.
    Augusti KT; Kurup PA
    Indian J Biochem; 1969 Mar; 6(1):36-9. PubMed ID: 4332123
    [No Abstract]   [Full Text] [Related]  

  • 10. Metabolic effects of butylbiguanide during long lasting intravenous glucose infusion in normal human subjects.
    Gomez F; Felber JP
    Horm Metab Res; 1970 Mar; 2(2):72-5. PubMed ID: 5520911
    [No Abstract]   [Full Text] [Related]  

  • 11. Antidiabetic drugs after the University Group Diabetes Program (UGDP).
    Karam JH; Matin SB; Forsham PH
    Annu Rev Pharmacol; 1975; 15():351-66. PubMed ID: 1096790
    [No Abstract]   [Full Text] [Related]  

  • 12. Effect of glurenorm on immunohistochemical changes in pancreatic beta cells of rats in experimental diabetes.
    Koyuturk M; Ozsoy-Sacan O; Bolkent S; Yanardag R
    Indian J Exp Biol; 2005 Mar; 43(3):268-71. PubMed ID: 15816415
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sulfonylureas improve insulin binding and insulin action in non-insulin-dependent diabetes mellitus.
    Beck-Nielsen H; Hjøllund E; Pedersen O; Richelsen B; Sørensen NS
    Diabetes Care; 1984; 7 Suppl 1():100-5. PubMed ID: 6428842
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The toxicology of glisoxepide, a new oral antidiabetic. Results of animal studies].
    Tettenborn D
    Arzneimittelforschung; 1974 Mar; 24(0):409-18. PubMed ID: 4408138
    [No Abstract]   [Full Text] [Related]  

  • 15. [Differential therapy using oral antidiabetics].
    Mehnert H
    Internist (Berl); 1971 Nov; 12(11):468-75. PubMed ID: 4943878
    [No Abstract]   [Full Text] [Related]  

  • 16. Hepatic effects of oral hypoglycemic drugs.
    Davidoff F
    Fed Proc; 1977 Dec; 36(13):2724-7. PubMed ID: 336410
    [No Abstract]   [Full Text] [Related]  

  • 17. Different amounts of insulin secretion following an equal total decrease of blood glucose as an indication of possible extrapancreatic activities of different sulfonylurea drugs.
    Beyer J; Haupt E; Cordes U; Kutschera J; Schöffling K
    Horm Metab Res; 1973 Jan; 5(1):9-13. PubMed ID: 4196346
    [No Abstract]   [Full Text] [Related]  

  • 18. [On 2-benzolsulfonylamine-5(beta-methoxyethoxy)-pyrimidine (Glycodiazine). VI. Experiments on the mechanism of action of the oral antidiabetic Glycodiazine in healthy test persons].
    Gerhards E; Nieuweboer B; Gutsche H
    Arzneimittelforschung; 1968 May; 18(5):570-7. PubMed ID: 5756198
    [No Abstract]   [Full Text] [Related]  

  • 19. Clinical and metabolic observations with a new synthetic oral antidiabetic agent, glipizide.
    D'Onofrio F; Pempinello R; Romis L
    Arzneimittelforschung; 1972 Nov; 22(11):1879-81. PubMed ID: 4679059
    [No Abstract]   [Full Text] [Related]  

  • 20. Oral agents for the treatment of type 2 diabetes mellitus: pharmacology, toxicity, and treatment.
    Harrigan RA; Nathan MS; Beattie P
    Ann Emerg Med; 2001 Jul; 38(1):68-78. PubMed ID: 11423816
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.